First Time Loading...

Green Cross Health Ltd
NZX:GXH

Watchlist Manager
Green Cross Health Ltd Logo
Green Cross Health Ltd
NZX:GXH
Watchlist
Price: 1 NZD Market Closed
Updated: May 6, 2024
Section:
 

Relative Value

The Relative Value of one GXH stock under the Base Case scenario is 2.29 NZD. Compared to the current market price of 1 NZD, Green Cross Health Ltd is Undervalued by 56%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GXH Relative Value
Base Case
2.29 NZD
Undervaluation 56%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
96
vs Industry
75
Median 3Y
0.3
Median 5Y
0.3
Industry
0.6
More Details
2.8
P/E
P/E
Price to Earnings
2.8
vs History
96
vs Industry
61
Median 3Y
5.7
Median 5Y
8.6
Industry
16.4
More Details
3.8
P/OCF
P/OCF
Price to OCF
3.8
vs History
31
vs Industry
57
Median 3Y
3.2
Median 5Y
3.2
Industry
8
More Details
5.6
P/FCFE
P/FCFE
Price to FCFE
5.6
vs History
53
vs Industry
45
Median 3Y
6.9
Median 5Y
5.9
Industry
15.7
More Details
0.9
P/B
P/B
Price to Book Value
0.9
vs History
96
vs Industry
60
Median 3Y
1.1
Median 5Y
1.1
Industry
1.6
More Details
0.3
EV/S
EV/S
Enterprise Value to Sales
0.3
vs History
85
vs Industry
66
Median 3Y
0.4
Median 5Y
0.4
Industry
0.7
More Details
0.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.6
vs History
58
vs Industry
82
Median 3Y
0.6
Median 5Y
0.6
Industry
2.2
More Details
5.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
5.2
vs History
80
vs Industry
52
Median 3Y
5.8
Median 5Y
6.1
Industry
8.4
More Details
5.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
5.2
vs History
80
vs Industry
57
Median 3Y
5.8
Median 5Y
6.1
Industry
12.7
More Details
6.5
EV/OCF
EV/OCF
Enterprise Value to OCF
6.5
vs History
11
vs Industry
46
Median 3Y
4.5
Median 5Y
4.5
Industry
9.1
More Details
7.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
7.7
vs History
15
vs Industry
44
Median 3Y
5
Median 5Y
5.1
Industry
12.6
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
87
vs Industry
57
Median 3Y
0.9
Median 5Y
0.9
Industry
1.1
More Details

Multiples Across Competitors

GXH Competitors Multiples
Green Cross Health Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NZ
Green Cross Health Ltd
NZX:GXH
143.5m NZD 0.2 2.8 5.2 5.2
ZA
Clicks Group Ltd
JSE:CLS
72.8B Zac 0 0 0 0
ZA
Dis-Chem Pharmacies Ltd
JSE:DCP
28.4B Zac 0 0 0 0
US
Walgreens Boots Alliance Inc
NASDAQ:WBA
15B USD 0.1 -2.5 5.2 11.6
BR
Raia Drogasil SA
BOVESPA:RADL3
45B BRL 1.3 42.6 12.9 23.1
CN
Yifeng Pharmacy Chain Co Ltd
SSE:603939
45.7B CNY 2 31.7 22.2 22.2
JP
MatsukiyoCocokara & Co
TSE:3088
927.9B JPY 0.9 18.3 9.1 11.7
SA
Al Nahdi Medical Company SCJSC
SAU:4164
17.8B SAR 2 19.9 11.2 18.5
MX
Corporativo Fragua SAB de CV
BMV:FRAGUAB
77.1B MXN 0.7 17.1 7.8 9.2
JP
Cosmos Pharmaceutical Corp
TSE:3349
582.5B JPY 0.6 24.2 11.4 18.4
CN
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
25.3B CNY 1 19.6 15 15

See Also

Summary
GXH intrinsic value, competitors valuation, and company profile.
DCF Valuation
GXH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GXH stock valuation using valuation multiples.
Wall Street Estimates
GXH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GXH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.